https://www.pharmatutor.org/pharma-news/2016/vm-biopharma-receive-fda-fast%20track-designation-for-vm202
VM BioPharma receive FDA Fast Track Designation for VM202 | PharmaTutor
Dr. Seungshin Yu, head of new business development of ViroMed Co. Ltd. The Fast Track designation, coupled with the recent Orphan Drug designation from the...
fast trackvmbiopharmareceivefda